Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 22, 2010 - Issue 6
383
Views
33
CrossRef citations to date
0
Altmetric
Review Article

Refractory ceramic fiber (RCF) toxicity and epidemiology: A review

&
Pages 500-521 | Received 15 Oct 2009, Accepted 01 Dec 2009, Published online: 13 Apr 2010

References

  • Aaron SD, Dales RE, Cardinal P. 1999. How accurate is spirometry at predicting restrictive pulmonary impairment? CHEST 115:869–873.
  • Agence française de sécurité sanitaire de l’environment et du travail (AFSSET). 2007. Les fibres minérales artificielles, évaluation de l’exposition de la population générale et des travailleurs. Saisine 2004/012 Rapport Final Relatif aux Fibres. April 2007. Available online at: http://www.afsset.fr/upload/bibliotheque/984122194670525373692769644950/fibres_minerales_artificielles_siliceuses_2007.pdf.
  • Agency for Toxic Substances and Disease Registry (ATSDR). 2000. Asbestos toxicity physiologic effects. Hosted on the ATSDR Web site. Available online at: http://www.atsdr.cdc.gov/HEC/CSEM/asbestos/physiologic_effects.html.
  • Agency for Toxic Substances and Disease Registry (ATSDR). 2001. Toxicological Profile for Asbestos. September 2001. Atlanta, Georgia. http://www.atsdr.cdc.gov/toxprofiles/tp61.html.
  • Agency for Toxic Substances and Disease Registry (ATSDR). 2004. Toxicological Profile for Synthetic Vitreous Fibers. September 2004. Atlanta, Georgia. http://www.atsdr.cdc.gov/toxprofiles/tp161.pdf.
  • Anderson HA, Selikoff IJ. 1978. Pleural reactions to environmental agents. Fed Proc 37:2496–2500.
  • Baris YI, Bilir N, Artvinli M, Sahin AA, Kalyoncu F, Sebastien P. 1988. An epidemiological study in an Anatolian village environmentally exposed to tremolite asbestos. Br. J. Ind. Med 45:838–840.
  • Bazas T, Oakes D, Gilson JC, Bazas B, McDonald JC. 1985. Pleural calcification in Northwest Greece. Environ. Res 38:239–247.
  • Bellmann B, Muhle H, Creutzenberg O, Ernst H. 2001. Effects of nonfibrous particles on ceramic fiber (RCF1) toxicity in rats. Inhal. Toxicol 13:101–125.
  • Bender JR, Hadley JG. 1994. Glass fiber manufacturing and fiber safety: The producer’s perspective. Environ. Health Perspect 102(Suppl 5):37–40.
  • Bernstein DM, Morscheidt C, Grimm H–,G, Thé,venaz P, Teichert U. 1996. Evaluation of soluble fibers using the inhalation biopersistence model a nine-fiber comparison. Inhal. Toxicol 8:345–385.
  • Bernstein DM, Riego-Sintes JM, Ersboell BK, Kunert J. 2001a. Biopersistence of synthetic mineral fibers as a predictor of chronic inhalation toxicity in rats. Inhal. Toxicol 13:823–849.
  • Bernstein DM, Riego-Sintes JM, Ersboell BK, Kunert J. 2001b. Biopersistence of synthetic mineral fibers as a predictor of chronic intraperitoneal injection tumour response in rats. Inhal. Toxicol 13:851–875.
  • Bernstein DM, Donaldson K, Decker U, Gaering S, Kunzendorf P, Chevalier J, Holm S. E. 2008. A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles. Inhal. Toxicol 20:1009–1028.
  • Bianchi C, Brollo A, Ramani L, Zuch C. 1997. Pleural plaques as risk indicators for malignant pleural mesothelioma: A necropsy-based study. Am. J. Ind. Med 32:445–449.
  • Boutin C, Viallat JR, Steinbauer J, Massey DG, Carpin D, Mouries JC. 1986. Bilateral pleural plaques in Corsica: A non-occupational asbestos exposure marker. Eur. J. Respir. Dis 69:4–9.
  • Boutin C, Viallat JR, Steinbauer J, Dufour G, Gaudichet A. 1989. Bilateral pleural plaques in Corsica: A marker of non-occupational asbestos exposure. IARC Sci. Publ 90:406–410.
  • Bresnitz EA, Gilman MJ, Gracely EJ, Airoldi J, Vogel E, Gefter W. 1993. Asbestos-related radiographic abnormalities in elevator construction workers. Am. Rev. Respir. Dis 147:1341–1344.
  • Brown RC, Sébastien P, Bellmann B, Muhle H. 2000. Particle contamination in experimental fiber preparations. Inhal. Toxicol 12(Suppl 3):99–107.
  • Brown RC, Bellmann B, Muhle H, Davis JMG, Maxim LD. 2005. Survey of the biological effects of refractory ceramic fibres: Overload and its possible consequences. Ann. Occup. Hyg 49:295–307.
  • Bunn WB, Bender JR, Hesterberg TW, Chase GR, Konzen JL. 1993. Recent studies of man-made vitreous fibres. J. Occup. Med 35:101–113.
  • Burge PS, Calvert IA, Trethowan WN, Harrington JM. 1995. Are the respiratory health effects found in manufacturers of ceramic fibers due to the dust rather than the exposure to fibers? Occup. Environ. Med 52:105–109.
  • Cai SX, Zhang CH, Zhang X, Morinaga K. 2001. Epidemiology of occupational asbestos-related diseases in China. Ind. Health 39:75–83.
  • Cerny FJ. 1987. Breathing pattern during exercise in young black and Caucasian subjects. J Appl Physiol 62:2220–2223.
  • Chen J, Lou J, Liu Z. 2003. Pulmonary function in fur-processing workers: A dose-response relationship. Arch Environ Health 58:37–41.
  • Cheng RT, McDermott HJ, Gia GM, Cover TL, Duda MM. 1992. Exposures to refractory ceramic fiber in refineries and chemical plants. Appl. Occup. Environ. Hyg 7:361–366.
  • Cherniak RM, Raber MD. 1972. Normal standards for ventilatory function using an automated wedge spirometer. Am. Rev. Respir. Dis 106:38–46.
  • Cherrie JW, Bodsworth PL, Cowie HA, Groat SK, Pettie S, Dodgson J. 1989. A report on the environmental conditions at seven European ceramic fibre plants. IOM report TM/89/07. Edinburgh: Institute of Occupational Medicine.
  • Christen B, Wegmann W, Vogt P. 1997. Clinical pathology and histology of pleural plaques. Indoor Built Environ 6:79–85.
  • Clarke CC, Mowat FS, Kelsh MA, Roberts MA. 2006. Pleural plaques: A review of diagnostic issues and possible nonasbestos factors. Arch. Environ. Occup. Health 61:183–192.
  • Constantopoulos SH, Goudevenos JA, Saratzis N, Langer AM, Selikoff I. J, Moutospoulos HM. 1985. Metsovo lung: Pleural calcification and restrictive lung function in north western Greece. Environmental exposure to mineral fibre as etiology. Environ. Res 38:319–331.
  • Copley S, Wells A, Rubens M, Chabat F, Sheehan R, Musk A, Hansell D. 2001. Functional consequences of pleural disease evaluated with chest radiography and CT. Radiology 220:237–243.
  • Coplu L, Bumortier P, Demir AU, Selcuk ZT, Kalyoneu F, Kisacik G, DeVuyst P, Sahin AA, Baris YL. 1996. An epidemiological study in an Anatolian village in Turkey environmentally exposed to tremolite asbestos. J. Environ. Pathol. Toxicol. Oncol 15:177–182.
  • Cowie HA, Wild P, Beck J, Auburtin G, Piekarski C, Massin N, Cherrie JW, Hurley JF, Miller BG, Groat S, Soutar CA. 2001. An epidemiological study of the respiratory health of workers in the European refractory ceramic fibre (RCF) industry. Occup. Environ. Med 58:800–810.
  • Crapo J. 2005. Testimony: A fair and efficient system to resolve claims of victims for bodily injury caused by asbestos, and for other purposes. April 26, 2006. Available online at: http://judiciary.senate.gov/hearings/testimony.cfm?id=1482&wit_id=4237.
  • Crapo RO, Morris AH. 1981. Standardized single-breath normal values for carbon monoxide diffusing capacity. Am. Rev. Respir. Dis 123:185–189.
  • Crapo RO, Morris AH, Gardner RM. 1981. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am. Rev. Respir. Dis 123:659–664.
  • Crapo RO, Morris AH, Clayton PD, Nixon CR. 1982. Lung volumes in healthy nonsmoking adults. Bull. Eur. Physiopathol. Respir 18:419–425.
  • Cullen MR, Barnett MJ, Balmes JR, Cartmel B, Redlich CA, Brodkin CA, Barnhart S, Rosenstock L, Goodman GE, Hammar S, Thronquist MD, Omenn GS. 2005. Predictors of lung cancer among asbestos-exposed men in the β-carotene and retinol efficacy trial. Am. J. Epidemiol 161:260–270.
  • Davis JMG. 1994. The role of clearance and dissolution in determining the durability or biopersistence of mineral fibers. Environ. Health Perspect 102(Suppl 5):113–117.
  • Davis JMG, Addison J, Bolton RE, Donaldson K, Jones AD, Wright A. 1984. The pathogenicity of fibrous ceramic aluminum silicate glass administered to rats by inhalation or peritoneal injection. In: Biological Effects of Man-Made Mineral Fibers. Vol. 2. Copenhagen: World Health Organization Regional Office for Europe, 203–322.
  • Dement JM, Welch L, Bingham E, Cameron B, Rice C, Quinne P, Ringen K. 2003. Surveillance of respiratory diseases among construction and trade workers at department of energy nuclear sites. Am. J. Ind. Med 43:559–573.
  • Demers RY, Neale AV, Robins T, Herman SC. 1990. Asbestos-related pulmonary disease in boilermakers. Am. J. Ind. Med 17:327–339.
  • De Vuyst P, Dumortier P, Swaen GMH, Pairon JC, Brochard P. 1995. Respiratory health effects of man-made vitreous (mineral) fibres. Eur. Respir. J 8:2149–2173.
  • Dweik RA, Mazzone PJ. 2004. Occupational lung diseases. Hosted online by The Cleveland Clinic. Available online at: http://my.clevelandclinic.org/disorders/occupational_lung_disease/pul_overview.aspx.
  • Edelman D. 1988. Asbestos exposure, pleural plaques and the risk of lung cancer. Int. Arch. Occup. Environ. Health 60:389–393.
  • Edge JR. 1976. Asbestos related disease in Barrow-in-Furness. Environ. Res 11:244–247.
  • Edge JR. 1979. Incidence of bronchial carcinoma in shipyard workers with pleural plaques. Ann. N.Y. Acad. Sci 30:289–294.
  • Ehrlich R, Li1is R, Chan E, Nicholson WJ, Selikoff IJ. 1992. Long term radiological effects of short term exposure to amosite asbestos among factory workers. Br. J. Ind. Med 49:268–275.
  • Environmental Resources Management (ERM). 1995. Description and characterization of the ceramic fibres industry of the European Union Reference 3059. ERM is a trading name of ERL, Environmental Resources Limited. Brussels, Belgium.
  • Epler G. 2001. Dynamics of disease: Environmental and occupational lung diseases. Available online at: http://www.epler.com/occu2.html.
  • European Ceramic Fibres Industry Association (ECFIA). 2000. Code of Practice Working With Refractory Ceramic Fibres (RCF). October 2000. CodePrac/EN/a 10-2000. Paris, France. Available online at: http://www.ecfia.eu/00_files/04/2007-11-code-of-practice.pdf.
  • European Ceramic Fibres Industry Association (ECFIA). 2006. Good Working Practices High Temperature Insulation Wools (HTIW). January 2006. Ref No: RCF/0598. Paris, France. Available online at: http://www.ecfia.eu/00_files/04/ww_HTIW_english.pdf.
  • Fayerweather WE, Bender JR, Hadley JG, Eastes W. 1997. Quantitative risk assessment for a glass fiber insulation product. Regul. Toxicol. Pharmcol 25:103–120.
  • Federal Register. 2005. Part II, Department of Labor, Mine Safety and Health Administration, 30 CFR Parts 56, 57, and 71. Asbestos Exposure Limit; Proposed Rule. Vol. 70, No. 145, Friday, July 29, 2005, pp. 43950–43989.
  • Fischbein A, Luo JCJ, Rosenfeld S, Lacher M, Miller A, Rosenbaum A. 1991. Respiratory findings among iron workers: Results from a clinical survey in the New York metropolitan area and identification of health hazards from asbestos in place at work. Br. J. Ind. Med 48:404–411.
  • Fischbein A, Luo JCJ, Lacher M, Rosenfeld S, Rosenbaum A, Miller A, Solomon SJ. 1993. Respiratory findings among millwright and machinery workers: Identification of health hazards from asbestos in place at work. Environ. Res 61:25–35.
  • Fletcher DE. 1971. Asbestos-related chest disease in joiners. Proc. R. Soc. Med 64:837–838.
  • Fletcher DE. 1972. A mortality study of shipyard workers with pleural plaques. Br. J. Ind. Med 29:142–145.
  • Floyd C, Hepburn RH. 1939. Calcification of the pleura. Am. Rev. Tuberc 40:215–223.
  • Friar JJ, Phillips AM. 1989. Exposure to ceramic man-made mineral fibers. In: Proceedings of the Symposium on Mineral Fibers in the Non-Occupational Environment. Lyon, France: International Agency for Research on Cancer, 299–303.
  • Gantner BA. 1986. Respiratory hazard from removal of ceramic fiber insulation from high temperature industrial furnaces. Am. Ind. Hyg. Assoc. J 47:530–534.
  • Genevois PA, de Maertelaer V, Madani A, Winant C, Sergent G, De Vuyst P. 1998. Asbestosis, pleural plaques and diffuse pleural thickening: Three distinct benign responses to asbestos exposure. Eur. Respir. J 11:1021–1027.
  • George RB. 2005. Chest Medicine: Essentials of Pulmonary and Critical Care Medicine. 5th ed. New York: Lippincott Willians & Wilkins.
  • Gibbs GW. 1979. Etiology of p1eural calcification: A study of Quebec chrysotile asbestos miners and millers. Arch. Environ. Health 34:76–83.
  • Goldberg M. 2005. Are lung and pleural benign asbestos induced diseases a preliminary step in the pathogenic process of mesothelioma and lung cancer development? Occup. Environ. Med 62:663–664.
  • Groat S, Kauffer E, Lovett M, Miller BG, Kidd MW, Davies LST, McIntosh C, Vigneron JC, Cherrie JW, Johnston A, Robertson A, Hurkey JF. 1999. Epidemiological research in the European ceramic fibre industry 1994–1998. Vol. 1. Workplace concentrations of airborne dust and fibres. IOM Report TM/99/01. Edinburgh: Institute of Occupational Medicine.
  • Gross P, Westrick ML, Schrenk HH, McNerney JM. 1956. The effects of synthetic ceramic fiber dust upon the lungs of rats. AMA Arch. Ind. Health 13:161–166.
  • Hall GS, Rice CH, Lockey JE, LeMasters GK, Gartside PS. 1997. A comparison of exposures to refractory ceramic fibres over multiple work shifts. Ann. Occup. Hyg 41:555–560.
  • Hankinson JL, Odencrantz JR, Fedan KB. 1999. Spirometric reference values from a sample of the general U.S. population. Am. J. Respir. Crit. Care Med 159:179–187.
  • Harries PG, Mackenzie FAF, Sheers G, Kemp JH, Oliver TP, Wright DS. 1972. Radiological survey of men exposed to asbestos in naval dockyards. Br. J. Ind. Med 29:274–279.
  • Hasanoglu HC, Gokirmak M, Baysal T, Yildirim Z, Koksal N, Onal Y. 2003. Environmental exposure to asbestos in eastern Turkey. Arch. Environ. Health 58:144–150.
  • Head IW, Wagg RM. 1980. A survey of occupational exposure to man-made mineral fibre dust. Ann. Occup. Hyg 23:235–258.
  • Health Council of the Netherlands: Dutch Expert Committee on Occupational Standards (DECOS). 1995. Man made mineral fibers (MMMF)—Health based recommended occupational exposure limits. The Hague: Health Council of the Netherlands. Publication No. 1995/02WGD; ISBN: 90-5549-085-7.
  • Hegewald MJ, Crapo RO. 2007. Socioeconomic status and lung function. CHEST 132:1608–1614.
  • Hesterberg TW, Hart GA. 2001. Synthetic vitreous fibers: A review of toxicology research and its impact on hazard classification. Crit. Rev. Toxicol 31:1–53.
  • Hesterberg TW, Miiller WC, McConnell EE, Chevalier J, Hadley JG, Bernstein DM, Thévenaz P, Anderson R. 1993. Chronic inhalation toxicity of size-separated glass fibers in Fischer 344 rats. Toxicol. Sci 20:464–476.
  • Hesterberg TW, Miiller WC, Thévenaz P, Anderson R. 1995. Chronic inhalation studies of man-made vitreous fibres: Characterization of fibres in the exposure aerosol and lungs. Ann. Occup. Hyg 39:637–653.
  • Hesterberg TW, Miiller WC, Musselman RP, Kamstrup O, Hamilton RD, Thévenaz P. 1996. Biopersistence of man-made vitreous fibers and crocidolite asbestos in the rat lung following inhalation. Fundam. Appl. Toxicol 29:267–279.
  • Hesterberg TW, Chase G, Axten C, Miiller WC, Musselman RP, Kamstrup O, Hadley J, Morscheidt C, Bernstein DM, Thévenaz P. 1998. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol. Appl. Pharmcol 151:262–275.
  • Hillerdal G. 1978. Pleural plaques in a health survey material. Frequency, development, and exposure to asbestos. Scand. J. Respir. Dis 59:257–263.
  • Hillerdal G. 1994. Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. CHEST 105:144–150.
  • Hillerdal G. 1997. Pleural plaques: Incidence and epidemiology, exposed workers and the general population. Indoor Built Environ 6:86–95.
  • Hillerdal G. 1980. Pleural plaques and risk for cancer in the County of Uppsala. Eur. J. Respir. Div. Suppl 107:111–117.
  • Hillerdal G. 2001. Radiological changes as markers of environmental exposure and environmental risk of lung cancer and mesothelioma. Presented at the UEPA 2001 Asbestos Health Effects Conference, May 24–25, Oakland, CA. Handout available online at: http://www.epa.gov/swerrims/ahec/summary/presentations/hillerdal.pdf.
  • Hilt B. 1987. Non-malignant asbestos diseases in workers in an electrochemical plant. Br. J. Ind. Med 44:621–626.
  • Hilt B, Lien JT, Lund-Larsen PG, Lund K, Langird S. 1986. Asbestos-related findings in the chest radiographs of the male population of the county of Telemark Norway—A cross-sectional study. Scand. J. Work Environ. Health 12:567–573.
  • Hilt B, Langard S, Rosenberg J. 1992. Exposure to asbestos and asbestos-related pulmonary changes among employees at a magnesium plant. Tidsskr. Nor. Laegeforen 112:897–900.
  • Hiraoka T, Ohkura M, Morinaga K, Kophyama N, Shimazu K, Ando M. 1998. Anthophyllite exposure and endemic pleural plaques in Kumamoto, Japan. Scand. J. Work Environ. Health 24:392–397.
  • Hori H, Higashi T, Fujino A, Yamato H, Ishimatsu S, Oyabu T, Tanaka I. 1993. Measurement of airborne ceramic fibers in manufacturing and processing facilities. Ann. Occup. Hyg 37:523–629.
  • Horii H, Nagasaka Y, Yamada Y. 1992. Asbestos related pleural thickenings in Japanese sake brewers. Int. Arch. Occup. Environ. Health 64:315–319.
  • Hosoda Y, Saitoh N, Hiraga Y, Harabuchi I. 1988. Asbestos related pleural plaques among seamen. In: Proceedings of the Vllth International Pneumoconiosis Conference, August 23–26, 1988, Pittsburgh, Part I, 402–404.
  • Hromek J. 1962. Occurrence of characteristic pleural findings in the inhabitants of the western section of Region Jihlava. Rozhl. Tuberk. Nemocech. Plicn 22:405–415.
  • Industrial Industries Advisory Council (IIAC). 2008. Position Paper 23. Pleural Plaques. United Kingdom. Available online at: http://www.iiac.org.uk/pdf/pos_papers/pp23.pdf.
  • Institut National de la Recherche Scientifique (INRS). 1997. Fibres minérals artificielles et amiante. Rapport du groupe scientifique pour la surveillance des atmospheres de travail (9G2SAT). Documents poir le médicin du travail No. 69.
  • Institut National de la Recherche Scientifique (INRS). 2003. Exposition professionnelle aux fibres céramiques réfractaires. Mesures de prevention lolls de l’utilisation. Cahiers de notes documentaries—Hygiène et sècuritè du traivail No. 191, 2e trimestre, 2003. ND 2189-191-03. Available online at: http://www.inrs.fr/inrs-pub/inrs01.nsf/inrs01_catalog_view/26455355F794B848C1256DC10049C631/File/nd2189.pdf.
  • Institute of Medicine and National Research Council. 2009. A review of the NIOSH Roadmap for Research on Asbestos Fibers and Other Elongate Mineral Particles. Washington, DC: The National Academies Press. Available online at: http://books.nap.edu/openbook.php?record_id=12697&page=54.
  • International Agency for Research on Cancer (IARC). 1999. Mechanisms of Fibre Carcinogenesis. Kane AB, Boffetta P, Saracci R, Wilbourn JD, eds. IARC Scientific Publications No. 140. Geneva: World Health Organization, International Agency for Research on Cancer. Available online at: http://monographs.iarc.fr/ENG/Publications/pub140/IARCpub140.pdf.
  • International Agency for Research on Cancer (IARC). 2002. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 81, Man-Made Vitreous Fibres. Lyon, France: IARC.
  • International Labour Organization (ILO). 2000. Code of practice on safety in the use of synthetic vitreous fibre insulation wools (glass wool rock wool slag wool). MESIW/2000/10. Geneva: International Labour Organization. Available online at: http://www.oit.org/public/english/standards/relm/gb/docs/gb277/pdf/stm-6a2.pdf.
  • International Life Sciences Institute (ILSI) Working Group. 2005. Testing of fibrous particles: Short-term assays and strategies. Report of an ILSI Risk Science Institute Working Group. Inhal. Toxicol 17:497–537.
  • Jones RN. 1997. Pleural plaques: Diagnostic problems and significance. Indoor Built. Environ 6:106–113.
  • Jones RN, Diem JE, Ziskand MM, Rodriguez M, Weill H. 1984. Radiographic evidence of asbestos effects on American marine engineers. J. Occup. Med 26:281–284.
  • Jones RN, Diem JE, Hughes JM, Hammad YY, Glindmeyer HW, Weill H. 1989. Progression of asbestos effects: A prospective longitudinal study of chest radiographs and lung function. Br. J. Ind. Med 46:97–105.
  • Kamstrup O, Ellehauge A, Collier CG, Davis JMG. 2002. Carcinogenicity studies after intraperitoneal injection of two types of stone wool fibres in rats. Ann. Occup. Hyg 46:135–142.
  • Karakoca Y, Emri S, Cangir AK, Baris YI. 1997. Environmental pleural plaques due to asbestos and fibrous zeolite exposure in Turkey. Indoor Built Environ 6:100–105.
  • Kauffer E, Vincent R. 2007. Occupational exposure to mineral fibres: Analysis of results stored on Colchic database. Ann. Occup. Hyg 312:31–142.
  • Kennedy SM, Vedal S, Muller N, Kassam A, Chang-Young M. 1991. Lung function and chest radiograph abnormalities among construction insulators. Am. J. Med 20:673–784.
  • Khan A, Jones C, MacDonald S. 2004. Asbestos related disease. Article published January 28, 2004, on Emedicine.com. Available online at: http://www.emedicine.com/radio/topic53.htm.
  • Kishimoto T, Morinaga K, Kira S. 2000. The prevalence of pleural plaque and/or pulmonary changes among construction workers in Okayama, Japan. Am. J. Ind. Med 37:291–295.
  • Kiviluoto R. 1965. Pleural plaques and asbestos: Further observations on endemic and other nonoccupational asbestosis. Ann. N.Y. Acad. Sci 132:235–239.
  • Kiviluoto R, Meurman LO, Hakama M. 1979. Pleural plaques and neoplasia in Finland. Ann. N.Y. Acad. Sci 330:31–33.
  • Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. 1976. The maximal expiratory flow-volume curve normal standards, variability, effects of age. Am. Rev. Respir. Dis 113:589–590.
  • Korotzer B, Ong S, Hansen J. 2000. Ethnic differences in pulmonary function in healthy nonsmoking Asian-Americans and European Americans. Am. J. Respir Crit Care Med 161:1101–1108.
  • Koskinen K, Zitting A, Tossavainen A, Rinne J.P., Roto P, Kivekas J, Reijula K, Huuskonen MS. 1998. Radiographic abnormalities among Finnish construction, shipyard and asbestos industry workers. Scand. J. Work Environ. Health 24:109–117.
  • Krantz S, Christensson B, Lundgren L, Paulsson B, Figler B, Persson A. 1994. Exposure to refractory ceramic fibers in smelters and foundries. Arbets Miljo Institutet (National Institute of Occupational Health) 34. Solna, Sweden.
  • Kraus T, Pfahlberg A, Zöbelein P, Gefeller O, Raithel J. 2004. Lung function among workers in the soft tissue paper producing industry. CHEST 125:731–736.
  • LeMasters GK, Lockey JE, Levin LS, McKay RT, Rice CH, Horvath EP, Papes DM, Lu JW, Feldman DJ. 1998. An industry-wide pulmonary study of men and women manufacturing refractory ceramic fibers. Am. J. Epidemiol 148:910–919.
  • LeMasters GK, Lockey JE, Yiin JH, Hilbert TJ, Levin LS, Rice CH. 2003. Mortality of workers occupationally exposed to refractory ceramic fibers. J. Occup. Environ. Med 45:440–450.
  • Lemen RA. 2006. Epidemiology of asbestos-related diseases and the knowledge that led to what is known today. In: Dodson RF, Hammar SP, eds. Asbestos—Risk Assessment, Epidemiology, and Health Effects. New York: Taylor and Francis. Chapter 6, pages 201–308.
  • Letourneux M. 1999. Risk assessment of benign asbestosis (dose-effect relationship, time-effect relationship, co-factors [article in French]. Rev. Mal. Respir 16(6 Pt 2):1270–1277.
  • Lilis R, Miller A, Godbold J, Chan E, Selikoff IJ. 1991. Radiographic abnormalities in asbestos insulators: Effects of duration from onset of exposure and smoking. Relationships of dyspnea with parenchymal and pleural fibrosis. Am. J. Ind. Med 20:1–15.
  • Linnainmaa M, Kangas J, Makinen M, Metsarinne S, Tossavainen A, Santti J, Veteli M, Savolainen H, Kalliokoski P. 2007. Exposure to refractory ceramic fibres in the metal industry. Ann. Occ. Hyg 51:509–516.
  • Liu XZ, Luo SW, Wang ZM, Zhan CL. 1990. An investigation of crocidolite contamination and mesothelioma in a rural area of China. Biomed. Environ. Sci 3(2):156–65.
  • Lockey J, LeMasters G, Rice C, Hansen K, Levin L, Shipley R, Spitz H, Wiot J. 1996. Refractory ceramic fiber exposure and pleural plaques. Am. J. Respir. Crit. Care Med 154:1405–1410.
  • Lockey JE, Levin L, LeMasters GK, McKay RT, Rice CH, Hansen KR, Papes DM, Simpson S, Medvedovic M. 1998. Longitudinal estimates of pulmonary function in refractory ceramic fiber manufacturing workers. Am. J. Respir. Crit. Care Med 157:1226–1233.
  • Lockey JE, LeMasters GK, Levin L, Rice C, Yiin J, Reutman S, Papes D. 2002. A longitudinal study of chest radiographic changes of workers in the refractory ceramic fiber industry. CHEST 121:2044–2051.
  • Luo S, Liu X, Mu S, Tsai SP, Wen CP. 2003. Asbestos-related disease from the epidemiological data. Occup. Environ. Med 60:35–42.
  • Manda-Stachouli C, Dalavanga Y, Daskalopoulos G, Leontaridi C, Cassiliou M, Constantopoulos SH. 2004. Decreasing prevalence of pleural calcifications among metsovites with nonoccupational asbestos exposure. CHEST 126:617–621.
  • Marsova M. 1964. Beitrag zur Atiologie der Pleuraverkalkungen. Z Tuberk 121:329–334.
  • Mast RW, McConnell EE, Anderson R, Chevalier J, Kotin P, Bernstein DM, Thévenaz P, Glass LR, Miiller WC, Hesterberg TW. 1995a. Studies on the chronic toxicity (inhalation) of four types of refractory ceramic fiber in male Fischer 344 rats. Inhal. Toxicol 7:425–467.
  • Mast RW, McConnell EE, Hesterberg TW, Chevalier J, Kotin P, Thévenaz P, Bernstein DM, Glass LR, Miiller W, Anderson R. 1995b. Multiple dose chronic inhalation study of size-separated kaolin refractory fiber in male Fischer 344 rats. Inhal. Toxicol 7:469–502.
  • Mast RW, Maxim LD, Utell MJ, Walker AM. 2000a. Refractory ceramic fiber: Toxicology, epidemiology, and risk analyses—A review. Inhal. Toxicol 12:359–399.
  • Mast RW, Yu CP, Oberdörster G, McConnell EE, Utell MJ. 2000b. A retrospective review of the carcinogenicity of refractory ceramic fiber in two chronic Fischer 344 rat inhalation studies: An assessment of the MTD and implications for risk assessment. Inhal. Toxicol 12:1141–1172.
  • Maxim LD, Kelly WP, Walters T, Waugh R. 1994. A multiyear workplace-monitoring program for refractory ceramic fibers. Regul. Toxicol. Pharmacol 20:S200–S215.
  • Maxim LD, Kelly WP, Walters T, Waugh R. 1997. A multi-year workplace-monitoring program for refractory ceramic fibers. Regul. Toxicol. Pharmacol 26:156–171.
  • Maxim LD, Allshouse JN, Deadman J, Kleck C, Kostka M, Webster D, Class P, Sébastien P. 1998a. CARE: A European programme for monitoring and reducing refractory ceramic fibre dust at the workplace: Initial results. Gefahrstoffe Reinhaltunz der Luft 58:97–103.
  • Maxim LD, Allshouse JN, Chen SH, Treadway J, Venturin D. 1998b. The development and use of respirator response functions as part of a workplace exposure monitoring program for control of potential respiratory hazards. Regul. Toxicol. Pharmacol 27:131–149.
  • Maxim LD, Allshouse JN, Chen SH, Treadway JC, Venturin DE. 2000a. Workplace monitoring of refractory ceramic fiber in the United States. Regul. Toxicol. Pharmcol 32:293–309.
  • Maxim LD, Allshouse JN, Venturin DE. 2000b. The random-effects model applied to refractory ceramic fiber data. Regul. Toxicol. Pharmacol 32:293–309.
  • Maxim LD, Yu CP, Oberdörster G, Utell MJ. 2003. Quantitative Risk Analyses for RCF: Survey and Synthesis. Regul. Toxicol. Pharmacol 38:400–416.
  • Maxim LD, Hadley JG, Potter RM, Niebo R. 2006. The role of fiber durability/biopersistence of silica-based synthetic vitreous fibers and their influence on toxicology. Regul. Toxicol. Pharm 56:42–62.
  • Maxim LD, Allshouse J, Fairfax RF, Lentz TJ, Venturing D, Walters TE. 2008. Workplace monitoring of occupational exposure to refractory ceramic fiber—A 17-year retrospective. Inhal. Toxicol 20:289–309.
  • McConnell EE, Kamstrup O, Musselman R, Hesterberg TW, Chevalier J, Miiller WC, Thévenaz P. 1994. Chronic inhalation study of size-separated rock and slag wool insulation fibers in Fischer 344/N rats. Inhal. Toxicol 6:571–561.
  • McConnell EE, Mast RW, Hesterberg TW, Chevalier J, Kotin P, Bernstein DM, Thévenaz P, Glass LR, Anderson R. 1995. Chronic inhalation toxicity of a kaolin-based refractory ceramic fiber in syrian golden hamsters. Inhal. Toxicol 7:503–532.
  • McConnell EE, Axten C, Hesterberg TW, Chevalier J, Miiller WC, Everitt J, Oberdörster G, Chase GR, Thévenaz P, Kotin P. 1999. Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure. Inhal. Toxicol 11:785–835.
  • McKay RT, LeMasters GK, Hilbert TJ, Levin LS, Tice CH, Borton EK, Lockey JE. (2010). A long term study of pulmonary function among U.S. Refractory Ceramic Fiber workers. Occup. Environ. Med. In press.
  • McLoud T, Woods B, Carrington C, Epler G, Gaensler E. 1985. Diffuse pleural thickening in an asbestos-exposed population: prevalence and causes. A J R Am. J. Roentgenol 144:9–18.
  • Metintas M, Metintas S, Hillerdal G, Ucgun I, Erginel S, Alatas F, Yildirim H. 2005. Nonmalignant pleural lesions due to environmental exposure to asbestos: A field-based, cross-sectional study. Eur. Respir. J 26:875–880.
  • Miles SE, Sandrini A, Johnson AR, Yates DH. 2008. Clinical consequences of asbestos-related diffuse pleural thickening: A review. J. Occ. Med. Toxicol Sept 8: 3:20–29.
  • Miller BG, Cherrie JW, Groat S, Kauffer E. 2007. Changes in workplace concentrations of airborne fibres in the European ceramic fibre industry, 1987–1996. Ann. Occup. Hyg 51:501–507.
  • Miraglia E, Meola G. 1960. Contributo allo studio delle cacificaziono pleuriche. Arch. Tisiol. Mal. Appar. Respir 15:1005–1023.
  • Moolgavkar SH, Luebeck EG, Turim J, Hanna L. 1999. Quantitative assessment of the risk of lung cancer associated with occupational exposure to refractory ceramic fibers. Risk Anal 19:599–611.
  • Moolgavkar SH, Luebeck EG, Turim J, Brown RC. 2000. Lung cancer risk associated with exposure to man-made fibers. Drug Chem Toxicol 23:223–242.
  • Moore MA, Boymel PM, Maxim LD, Turim J. 2002. Categorization and nomenclature of vitreous silicate wools. Regul. Toxicol. Pharmacol 35:1–13.
  • Morris JF. 1976. Spirometry in the evaluation of pulmonary function. West. J. Med 125:110–118.
  • Morris JF, Koski A, Johnson L. C. 1971. Spirometric standards for healthy non-smoking adults. Am. Rev. Respir. Dis 103:57–67.
  • Mukherjee S, de Klerk N, Palmer LJ, Olsen NJ, Pang SC, Musk WA. 2000. Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease. Am. J. Respir. Crit. Care Med 162:1807–1811.
  • Murie F. 2006. Comments on WHO Policy Paper on the Elimination of Asbestos-Related Diseases. Available online at: http://www.bwint.org/pdfs/WHO%20Policy%20Pape_on%20Asbestos.pdf
  • National Institute for Occupational Safety and Health (NIOSH). 2002. Health Effects of Occupational Exposure to Respirable Crystalline Silica. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control Prevention, National Institute for Occupational Safety and Health.
  • National Institute for Occupational Safety and Health (NIOSH). 2006. Criteria for a Recommended Standard Occupational Exposure to Refractory Ceramic Fibers. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control Prevention, National Institute for Occupational Safety and Health.
  • National Occupational Health and Safety Commission (NOHSC). 1990. Synthetic Mineral Fibers. National Standard for Synthetic Mineral Fibres [NOHSC:1004(1990)], National Code of Practice for the Safe Use of Synthetic Mineral Fibres [NOHSC:2006(1990)]. May 1990. Canberra, Australia: Australian Government Publishing Service. Available online at: http://www.safeworkaustralia.gov.au/NR/rdonlyres/4AC9EEA0-76D8-41BF-BEBE-DE519C9D5137/0/SyntheticMineralFibres.pdf.
  • National Occupational Health and Safety Commission (NOHSC). 1993. Code of Practice for the Safe Use of Synthetic Mineral Fibres. Canberra, Australia, 1 June 1993. Available online at: http://www.safework.sa.gov.au/uploaded_files/resCOPMinFibre.pdf.
  • National Research Council (NRC). 2000. Review of the U.S. Navy’s Exposure Standard for Manufactured Vitreous Fibers, Subcommittee on Manufactured Vitreous Fibers, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission on Life Sciences National Research Council. Wsshington, DC: National Academy Press.
  • Navari K, Farshidi H, Pour-Reza-Gholi F, Nafar M, Zand S, Pour HS, Eftekhaari T. E. 2008. Spiromety parameters in patients undergoing hemodialysis with bicarbonate and acetate dialysates. Iran. J. Kidney Dis 2:149–153.
  • Navratil M. 1971. Pleural calcifications due to asbestos exposure compared to relevant findings in the non-exposed population. In: Walton H, ed. Inhaled Particles III. Proceedings of the International Symposium London 1970. Old Woking: Unwin Bros, 695–703.
  • Navratil M, Trippe F. 1972. Prevalence of pleural calcification in persons exposed to asbestos dust, in the general population in the same district. Environ. Res 5:210–216.
  • Neef W. 1963. Beidseitiger Pleuraverkalkungen im Alter. Fortschr. Geb. Rontgenstr 99:623–638.
  • Newman L.S, Rose CS. 1989. Occupational Asbestosis and Related Diseases. Medical/Scientific Update, National Jewish Center for Immunology and Respiratory Medicine, 8, (8). Available online at: http://www.mutnicklaw.com/occupational.pdf.
  • Oberdörster G. 2000. Determinants of the pathogenicity of man-made vitreous fibers (MMVF). Int. Arch. Occup. Environ. Health 73(Suppl):S60–S68.
  • Occupational Health Clinics for Ontario Workers, Inc. 2004. Refractory Ceramic Fibers. Ontario, Canada. Available online at: http://ohcow.memberlodge.com/DocumentHandler.ashx?DocId=324.
  • Ohlson CG, Bodin L, Rydman T, Hogstedt C. 1985. Ventilatory decrements in former asbestos cement workers: A four year follow up. Occup. Environ. Med 42 6:612–616.
  • Oksa P, Koskinen H, Rinne JP, Zitting A, Roto P, Huuskonen MS. 1992. Parenchymal and pleural fibrosis in construction workers. Am. J. Ind. Med 21:561–567.
  • Oliver LC, Sprince NL, Greene R. 1991. Asbestos-related disease in public school custodians. Am. J. Ind. Med 19:303–316.
  • Oliver LC, Eisen EA, Greene R, Sprince NL. 1988. Asbestos-related pleural plaques and lung function. Am. J. Ind. Med 14:649–656.
  • Organization mondiale de la santé (OMS). 1998. Man-Made Mineral Fibres. Environmental Health Criteria 77. Programme international sur la sécurité des substances chimiques. Genève: Organization mondiale de la santé.
  • Ose H, Bittersohl G. 1972. Zur Epidemiologie der Pleuraasbestose. Z. Erkr. Atmungsorgane 136:165–174.
  • Ostiguy G, Vaillancourt C, Begin R. 1995. Respiratory health of workers exposed to metal dusts and foundry fumes in a copper refinery. Occup. Environ. Med 53(3):204–210.
  • Partanen T. 1992. Localized pleural plaques and lung cancer. Am. J. Ind. Med 22:185–192.
  • Pass H, Lott D, Lonardo F, Harbut M, Liu Z, Tang N, Carbone M, Webb C, Wali A. 2005. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N. Engl. J. Med 335:1564–1573.
  • Peipins LA, Lewin M, Campolucci S, Lybarger JA, Miller A, Middleton D, Weis C, Spence M, Black B, and Kapil V. 2003. Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environ. Health Perspect 111:1753–1759.
  • Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. 2005. Interpretive strategies for lung function tests. Number 5 in the series “ATS/ERS Task Force: Standardisation of Lung Function Testing.” Eur. Respir. J 26:948–968.
  • Perrault G, Dion C, Cloutier Y. 1992. Sampling and analysis of mineral fibers on construction sites. Appl. Occup. Environ. Hyg. J 7:323–326.
  • Pesola GR, Sunmonu Y, Huggins G, Ford JG. 2004. Measured diffusion capacity versus prediction equation estimates in Blacks without lung disease. Respiration 71:484–492.
  • Pott F, Roller M, Ziem U, Reiffer FJ, Bellmann B, Rosenbruch R, Huth F. 1989. Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats. In: Bignon J, Peto J, Saracci R, eds. Non-Occupational Exposure to Mineral Fibres. IARC Scientific Publications No. 90. Lyon, France: IARC Press, 173–179.
  • Pott F, Roller M, Rippe RM, Germann P-G, Bellmann B. 1991. Tumours by the intraperitoneal and intrapleural routes and their significance for the classification of mineral fibres. In: Brown RC, Hoskins JA, Johnson NF, eds. Mechanisms in Fibre Carcinogenesis. New York, London: Plenum Press, 547–565. (NATO ASI Series A: Life Sciences. Vol. 223.)
  • Prescott E, Vestbo J. 2009. Socioeconomic status and chronic obstructive pulmonary disease. Thorax 54:737–741.
  • Reid A, de Klerk N, Ambrosini G, Olsen N, Pang SC, Musk AW. 2005. The additional risk of malignant mesothelioma in former workers and residents of Wittenoom with benign pleural disease or asbestosis. Occup. Environ. Med 62; 665–669.
  • Reinhartz A. 2004. Fact sheet on pleural plaques. Hosted by the International Ban Asbestos Secretariat. Available online at: http://www.btinternet.com/∼ibas/ar_pleural_plaque_faq.htm.
  • Rey F, Boutin C, Viallat J. R, Steinbauer J, Alessandroni P, Jutisz P, DiGiambittista D, Billon-Galland MA, Hereng P, Dumortier P, De Vuyst P. 1994. Environmental asbestotic pleural plaques in Northeast Corsica: Correlations with airborne and pleural mineralogic analysis. Environ. Health Perspect 102 (Suppl 5):251–252.
  • Rice C, Lockey J, LeMasters G, Dimos J, Gartside P. 1994. Assessment of current fibre and silica exposure in the U.S. refractory ceramic fibre manufacturing industry. Ann. Occup. Hyg, 18(Suppl 1):739–744.
  • Rice C, Lockey JE, LeMasters GK, Levin L, Staley P, Hansen KR. 1997. Estimation of historical and current employee exposure to refractory ceramic fibers during manufacturing and related operations. Appl. Occup. Environ. Hyg 12:54–61.
  • Rice CH, Levin LS, Borton EK, Lockey JE, Hilbert TJ, LeMasters GK. 2005. Exposures to refractory ceramic fibers in manufacturing and related operations: A 10-year update. J. Occup. Environ. Hyg 2:462–473.
  • Rogers A, Yeung P, Berry G, Conaty G, Apthorpe L. 1997. Exposure and respiratory health of workers in the Australian refractory ceramic fibre production industry. Ann. Occup. Hyg 41(Suppl 1):261–266.
  • Rosenstock L, Barnhart S, Heyer NL, Pierson DL, Hudson LD. 1988. Relation among pulmonary function chest x-ray abnormalities and smoking status in an asbestos-exposed cohort. Am. Rev. Respir. Dis 138:272–277.
  • Rossiter CE, Harries PG. 1979. UK naval dockyard asbestosis study: Survey of the sample population aged 50–59 years. Br. J. Ind. Med 36:281–291.
  • Rossiter CE, Heath JR, Harries PG. 1980. Royal Naval dockyards asbestosis research project: Nine-year follow-up study of men exposed to asbestos in Devonport Dockyard. J. R. Soc. Med 73:337–344.
  • Rous V, Studeny J. 1970. Aetiology of pleural plaques. Thorax 25:270–284.
  • Rui F, De Zotti R, Negro C, Bovenzi M. 2004. A follow-up study of lung function among ex-asbestos workers with and without pleural plaques. Med. Lav 95:171–179.
  • Sakellariou K, Malamou-Mitsi V, Haritou A, Koumpaniou C, Stachouli C, Dimoliatis I.D., Constantopoulos SH. 1996. Malignant pleural mesothelioma from nonoccupational asbestos exposure in Metsovo (north-west Greece): Slow end of an epidemic? Eur. Respir. J 9:1206–1210.
  • Sanden Å,Järvholm, B., 1986. Pleural plaques respiratory symptoms and respiratory function in shipyard workers exposed to man-made mineral fibres. Occ. Med 36:86–89.
  • Sanden Å,Järvholm, B., 1991. A study of possible predictors of mesothelioma in shipyard workers exposed to asbestos. J. Occup. Med 33:770–773.
  • Sanden Å,Järvholm, B,Larsson S. 1993. The importance of lung function non-malignant diseases associated with asbestos, and symptoms as predictors of ischaemic heart disease in shipyard workers exposed to asbestos. Br. J. Ind. Med 50:785–790.
  • Schachter E.N., ZuskinE., Moshier E.L., Godbold J, Mustajbegovic J, Pucarin-Cvetkovic J, Chiarelli A.. 2009. Gender and respiratory findings in workers occupationally exposed to organic aerosols: A meta analysis of 12 cross-sectional studies. Environ. Health 8:1–16.
  • Schwartz DA. 1991. New developments in asbestos-induced pleural disease. CHEST 99:191–198.
  • Schwartz DA, Fuortes LJ, Galvin JR, Burmeister LF, Schmidt LE, Leistikow BN, Lamarte FP, Merchant JA. 1990. Asbestos-induced pleural fibrosis and impaired lung function. Am. Rev. Respir. Dis 141:321–326.
  • Sciences International, Inc. (SII). 1998. Quantitative risk assessment of refractory ceramic fibers in the occupational environment. Prepared for Refractory Ceramic Fibers Coalition. April 1998. Washington, DC.
  • Selikoff IJ. 1965. The occurrence of pleural calcification among asbestos insulation workers. Ann. N. Y. Acad. Sci 132:351–367.
  • Selikoff IJ, Lilis R, Levin G. 1990. Asbestotic radiological abnormalities among United States merchant marine seamen. Br. J. Ind. Med 47:292–297.
  • Sepulveda MJ, Merchant JA. 1983. Roentgenographic evidence of asbestos exposure in a select population of railroad workers. Am. J. Ind. Med 4:631–639.
  • Sheers G. 1979. Asbestos-associated disease in employees of Devonport Dockyard. Ann. N. Y. Acad. Sci 330:281–287.
  • Sheers G, Templeton AR. 1968. Effects of asbestos in dock yard workers. Br. Med. J 11:574–579.
  • Sichletidis L, Chloros D, Chatzidimitriou N, Tsiotsios I, Spyratos D, Patakas D. 2005. Longitudinal study of pleural plaques in a rural population with environmental exposure to asbestos. Pneumon 18:197–203.
  • Sichletidis L, Daskalopoulou E, Tsarou V, Pnevmatikos I, Chloros D, Vamvalis C. 1992. Five cases of pleural mesothelioma with endemic pleural calcifications in a rural area in Greece. Med. Lav 83:326–329.
  • Siegal W, Smith A.R. Greenberg L. 1943. The dust hazard in tremolite talc mining including roentgenologic findings in talc workers. Am. J. Roent 49:11–29.
  • Smith DD. 1994. Plaques cancer and confusion. CHEST 105:8–9.
  • Smith DM, Ortiz LW, Archuleta RF, Johnson NF. 1987. Long term health effects in hamsters and rats exposed chronically to man made vitreous fibers. Ann. Occup. Hyg 31:731–743.
  • Sood A, Gee JBL. 1997. Asbestos-related pleural plaques and diffuse pleural thickening: Functional consequences. Indoor Built Environ 6:114–118.
  • Soulat JM, Lauque D, Esquirol Y Depres M, Giron J, Claudel R, Carles P. 1999. High-resolution computer tomography abnormalities in ex-insulators annually exposure to asbestos dust. Am. J. Ind. Med 36:593–601.
  • Steinbauer J Boutin C, Viallat JR, Dufour G, Gaudichet A, Massey DG, Charpin D, Mouries JC. 1987. Pleural plaques and an asbestos environment in Northern Corsica. Rev. Mal. Respir 4:23–27.
  • Thermal Insulation Manufacturers Association (TIMA) Nomenclature Committee. 1993. Man-Made Vitreous Fibers: Nomenclature, Chemical and Physical Properties. Washington, DC: Refractory Ceramic Fibers Coalition (RCFC).
  • Thiringer G, Blomqvist N, Brolin I, Mattson SB. 1980. Pleural plaques in chest X-rays of lung cancer patients and matched controls (preliminary results). Eur. J. Respir. Dis 61(Suppl 107):119–122.
  • Trethowan WN, Burge PS, Rossiter CE, Harrington JM, Calvert IA. 1995. Study of the respiratory health of employees in seven European plants that manufacture ceramic fibers. Occup. Environ. Med 52:97–104.
  • Turim J, Brown RC. 2003. A dose response model for refractory ceramic fibers. Inhal. Toxicol 15:1103–1118.
  • UK Health and Safety Executive (HSE). 1998. Hazards from the use of refractory ceramic fibre. Information Document HSE 267/3. Available online at: http://www.hse.gov.uk/fod/infodocs/267_3v2.pdf.
  • UK Health and Safety Executive (HSE). 1994. Seven Steps to Successful Substitution of Hazardous Substances. HSG110. HSE Books. ISBN 0 7176 0695 3.
  • United Nations Environment Programme. 2006. Summary consensus report of the World Health Organization Workshop on mechanisms of fibre carcinogenesis and assessment of chrysotile asbestos substitutes. UNEP/FAO/RC/COP.3/INF/9. Issued September 13, 2006. Available online at: http://www.pic.int/COPs/COP3/yinf9)/English/K0652702%20COP-3-INF9.doc
  • US Geological Survey (USGS). 2006. Worldwide asbestos supply and consumption trends from 1900 through 2003. United States Department of the Interior, United States Geological Survey, Circular 1298. Washington, DC. Available online at: http://pubs.usgs.gov/circ/2006/1298/c1298.pdf.
  • van Cleemput JV, De Raeve H, Verschakelen JA, Rombouts J, Lacquet LM, Nemery B. 2001. Surface of localized pleural plaques quantitated by computed tomography scanning. No relation with cumulative asbestos exposure and no effect on lung function. Am. J. Resp. Crit. Care Med 163:705–710.
  • Van den Bergen EA, Rocchi PSJ, Boogaard PJ. 1994. Ceramic fibers and other respiratory hazards during the renewal of the refractory lining in a large industrial furnace. Appl. Occup. Environ. Hyg 9:32–35.
  • Verma DK, Sahal D, Kurtz LA, Finkelstein MM. 2004. Current man-made mineral fibers (MMMF) exposures among Ontario construction workers. J. Occup. Environ. Hyg 1: 306–318.
  • Wain SL, Roggli VL, Foster WL Jr. 1984. Parietal pleural plaques asbestos bodies and neoplasia. A clinical, pathologic, and roentgenographic correlation of 25 consecutive cases. CHEST 86:707–713.
  • Wagner JC Berry G, Timbrell V. 1973. Mesotheliomata in rats after inoculation with asbestos and other materials. Br. J. Cancer 28:173–185.
  • Walker AM, Maxim LD, Utell M. 2002. Risk analysis for mortality from respiratory tumors in a cohort of refractory ceramic fiber workers. Regul. Toxicol. Pharmacol 35:95–104.
  • Warheit DB, Reed KL, Webb TR. 2001. Man-made respirable-sized organic fibers: What do we know about their toxicological profiles? Ind. Health 39:119–125.
  • Weiss W. 1993. Asbestos-related pleural plaques and lung cancer. CHEST 103:1854–1859.
  • Welch LS, Michaels D, Zoloff R. 1994. National Sheet Metal Worker Asbestos Disease Screening Program: Radiologic findings. Am. J. Ind. Med 25:635–648.
  • Wimmer H. 2005. High temperature wool working for the environment. DKG 82:E35–E40. Available online at: http://www.dkfg.de/pdf/dkfg/High-Temperature-Wool-Working-for-the-Environment-Heinz-Wimm.pdf.
  • Wimmer H, Class P. 2002. Refractory ceramic fibres: History and professional handling. Presented at the 46th International Colloquium on Refractories; Aachen, 16–17 October 2002. Available online at: http://www.dkfg.de/pdf/feuerfest/FF-Kol-Aachen-HeinzWimmer-PhilippeClass-RCF-History-2002.pdf.
  • Wojtczak J. 1994. Exposure to ceramic fibers in the work environment. I. Production kinds of ceramic fibers, changes in structure of these fibers, preliminary studies in the working environment. Med. Pr 45:479–486.
  • Wojtczak J, Lao I, Krajnow A. 1996. Exposure to ceramic fibers in the work environment. II. Occupational exposure to plants producing ceramic fiber. Med. Pr 47:559–567.
  • Wojtczak J, Swiercznska M, Maciejewska A. 1997. Exposure to ceramic fiber in the work environment. III. Occupational exposure to ceramic fibers in plants which produce and apply insulation materials made of ceramic fibers. Med. Pr 48:51–60.
  • Woźniak H, Weicek E. 1996. Refractory ceramic fibers kinds health effects after exposure TLVs [in Polish]. Med. Pr 47:393–399.
  • Yazicioglu S,, llcayto R, Balci K, Sayli B.S., Yorulmaz B. 1980. Pleural calcification, pleural mesotheliomas and bronchial cancers caused by tremolite dust. Thorax 35:564–569.
  • Young J, West S, Jackson J, Cantrell P. 1981. Prevalence of asbestos related lung disease among employees in non-asbestos industries. Med. J. Aust 1:464–467.
  • Yu CP, Oberdörster G. 2000. Dose-response and human cancer and non-cancer risk assessment of inhaled refractory ceramic fibers (RCF). A report prepared for the US Environmental Protection Agency, Washington, DC.
  • Yu CP, Zhang L, Oberdörster G, Mast RW, Glass LR, Utell MJ. 1994a. Deposition modeling of refractory ceramic fibers in the rat lung. J. Aerosol Sci 25: 407–417.
  • Yu CP, Zhang L, Oberdörster G, Mast R. W, Glass LR, Utell MJ. 1994b. Clearance of refractory ceramic fibers (RCF) from the rat lung: development of a model. Environ. Res 65:243–253.
  • Yu CP, Zhang L, Oberdörster G, Mast R. W, Maxim LD, Utell MJ. 1995a. Deposition of refractory ceramic fibers (RCF) in the human respiratory tract and comparison with rodent studies. Aerosol Sci. Technol 23:291–300.
  • Yu CP, Ding J, Zhang L, Oberdörster G, Mast R. W, Glass LR, Utell MJ. 1995b. Deposition and clearance modeling of inhaled kaolin refractory ceramic fibers (RCF) in hamsters-comparison between species. Inhal. Toxicol 7:165–177.
  • Yu CP, Ding J, Zhang L, Oberdörster G, Mast RW, Maxim LD, Utell MJ. 1996. A clearance model of refractory ceramic fibers (RCF) in the rat lung including fiber dissolution and breakage. J. Aerosol. Sci 27:151–160.
  • Zitting A. J. 1995. Prevalence of radiographic small lung opacities and pleural abnormalities in a representative adult population sample. CHEST 107:126–131.
  • Zitting A.J, Karjalainen A, Impivaara O, Kuusela T, Maki J, Tossavainen A, Jarvisalo J. 1996).Radiographic small lung opacities and pleural abnormalities in relation to smoking, urbanization status, and occupational asbestos exposure in Finland. J. Occup. Environ. Med 38:602–609.
  • Zoitos BK, De Meringo A, Rouyer E, Thélohan S, Bauer J, Law B, Boymel PM, Olson J. R, Christensen VR, Guldberg M, Koenig AR, Perander M. 1997. In vitro measurement of fiber dissolution rate relevant to biopersistence at neutral pH: An interlaboratory round robin. Inhal. Toxicol 9:525–540.
  • Zolov C, Bourilkov T, Babadjov L. 1967. Pleural asbestosis in agricultural workers. Environ. Res 1:287–292.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.